RLY-2608 | RLY-2608 : Allosteric Inhibitor of PIK3CA
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (0 reviews)
In Vivo
Control Compounds
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
PIK3CA (Mutant:WT, H1047R, E542K, E545K)
  • IC50:4 nM
  • IC50:48 nM
  • IC50:20 nM
  • IC50:70 nM
Allosteric
up to 100 nM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
In vitro kinome profile of RLY-2608. RLY-2608 was tested at a concentration of 10 μM by SelectScreen ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
tested on various cells lines for target engagement and cell proliferation

Potency
Cellular
In Vitro

PIK3CA (Mutant:WT, H1047R, E542K, E545K)

Mode of Action: Allosteric

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1158/2159-8290.CD-23-0944

Orthogonal Probes def

ALPELISIB

Chemical Information

Molecular Formula C29H14ClF5N6O2
SMILEs N#Cc1c(-c2cc(NC(=O)c3cc(F)cc(C(F)(F)F)c3)c3c(c2)C(=O)N[C@H]3c2cc(F)ccc2Cl)ccc2ncnn12
InChI InChI=1S/C29H14ClF5N6O2/c30-21-3-1-16(31)10-19(21)26-25-20(28(43)40-26)7-13(18-2-4-24-37-12-38-41(24)23(18)11-36)8-22(25)39-27(42)14-5-15(29(33,34)35)9-17(32)6-14/h1-10,12,26H,(H,39,42)(H,40,43)/t26-/m0/s1
Molecular weight 608.08 Da
AlogP 0.0
HBond acceptors 8
HBond donors 2
Atoms 57

References

Cross References

canSARPDB

Expert Reviews


(on 7 Jan 2025 )
Cellular Use Rating
Clinically active compound with a >10-fold window to PI3Ka WT. Highly selective for the alpha isoform. Quality tool.
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria